Saline Enema
NDC Package 67777-402-02
Package Information
Saline Enema (sodium phosphate monobasic, sodium phosphate dibasic) enemas is do not use more unless directed by a doctorSee WarningsAdults and children 12 years and older - 1 bottleChildren 2 to under 12 years - 1/2 bottleChildren under 2 years - Do not use. This formulation utilizes a enema delivery system. Marketed by Dynarex Corporation, this product is identified by NDC 67777-402 and is authorized under FDA application M007.
Identification & Billing
- RxCUI: 283100 - sodium phosphate, dibasic 7 GM / sodium phosphate, monobasic 19 GM in 118 ML Enema
- RxCUI: 283100 - sodium phosphate, dibasic 59.3 MG/ML / sodium phosphate, monobasic 161 MG/ML Enema
- RxCUI: 283100 - sodium phosphate, dibasic 3.5 GM / sodium phosphate, monobasic 9.5 GM per 59 ML Enema
- RxCUI: 283100 - sodium phosphate, dibasic 7 GM / sodium phosphate, monobasic 19 GM per 118 ML Enema
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 67777 - Dynarex Corporation
- 67777-402 - Saline Enema
- 67777-402-02 - 48 BOX in 1 CASE / 1 BOTTLE in 1 BOX (67777-402-01) / 133 mL in 1 BOTTLE
- 67777-402 - Saline Enema
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67777-402-02 identifies a specific commercial package of 48 box in 1 case / 1 bottle in 1 box (67777-402-01) / 133 ml in 1 bottle of Saline Enema, a human over the counter drug labeled by Dynarex Corporation. This enema is formulated for rectal use and contains sodium phosphate, dibasic; sodium phosphate, monobasic as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dynarex Corporation on August 29, 2012. The current certification is valid through December 31, 2026.
How is this Dynarex Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67777040202. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.